52807-5 |
Medical Coding Other Diagnoses, Comorbidities, and Complications |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
Medical Coding Other Diagnoses, Comorbidities, and Complications |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CARE |
|
52807-5 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
CARE Survey; Othr; Point in time; Random; Survey |
2.64 |
2.26 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
52808-3 |
Medical Coding Major Procedures (Diagnostic, Surgical, and Therapeutic Interventions) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
Medical Coding Major Procedures (Diagnostic, Surgical, and Therapeutic Interventions) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CARE |
|
52808-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
CARE Survey; Point in time; Random; Surg; Survey; Ther |
2.64 |
2.26 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
52809-1 |
Dose form |
Type |
Medication.current |
Pt |
Nom |
|
|
ACTIVE |
Dose form Current medication |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
52809-1 |
|
|
|
|
Observation |
|
|
|
0 |
Dose form Medication.current |
|
|
|
N |
|
Med; MEDS; Nominal; Point in time; Random; Typ |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5281-1 |
Polio virus 1 Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5281-1 |
|
Neut |
|
|
Both |
|
|
|
0 |
PV1 NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); i; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Polio virus type I; Poliovirus; PV; PV1; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
52810-9 |
Frequency |
NRat |
Medication.current |
Pt |
Qn |
|
|
ACTIVE |
Current medication, Frequency |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
52810-9 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
ATTACH; ATTACH.MEDS; Count/time; Med; MEDS; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
52811-7 |
HIPAA attachments |
- |
^Patient |
Pt |
- |
|
|
DEPRECATED |
Deprecated HIPAA attachments |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH |
|
52811-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated |
|
|
|
N |
|
Point in time; Random |
2.66 |
2.24 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
52812-5 |
Observation |
Aper |
Dial fld.spun |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Spun Dialysis fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
52812-5 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance spun Dial fld |
|
|
|
N |
|
Appearance; Diaf; Dialysate; Dialysis fluid; Nominal; Point in time; Random; SPEC; spun Dial fld; Supernat; Supernate |
2.79 |
2.24 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
52813-3 |
Observation |
Aper |
Plr fld.spun |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Spun Pleural fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
52813-3 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance spun Plr |
|
|
|
N |
|
Appearance; Nominal; Pleural; Pleural fluid; Point in time; Random; SPEC; spun Plr; Supernat; Supernate; thoracentesis fluid |
2.79 |
2.24 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
52814-1 |
Observation |
Aper |
Periton fld.spun |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Spun Peritoneal fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
52814-1 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance spun Prt |
|
|
|
N |
|
Appearance; Ascites; Ascitic fluid; Ascitis; Nominal; Peritoneal fluid; Point in time; Prt; Random; SPEC; spun Prt; Supernat; Supernate |
2.79 |
2.24 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
52815-8 |
Nucleated cells |
NCnc |
Pericard fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Pericardial fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
cells/uL |
0-9999 |
|
|
|
|
|
HEM/BC |
|
52815-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # Pcar Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.24 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
52816-6 |
Nucleated cells |
NCnc |
CSF |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
cells/uL |
0-99999 |
|
|
|
|
|
HEM/BC |
|
52816-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # CSF Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
2.24 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
52817-4 |
Nucleated cells |
NCnc |
Dial fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Dialysis fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
cells/uL |
0-99999 |
|
|
|
|
|
HEM/BC |
|
52817-4 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # Dial fld Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.24 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
52818-2 |
Nucleated cells |
NCnc |
Periton fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Peritoneal fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
cells/uL |
0-9999 |
|
|
|
|
|
HEM/BC |
|
52818-2 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # Prt Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.24 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
52819-0 |
Nucleated cells |
NCnc |
Plr fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Pleural fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
cells/uL |
0-9999 |
|
|
|
|
|
HEM/BC |
|
52819-0 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # Plr Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid |
2.7 |
2.24 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
5282-9 |
Polio virus 1 Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Polio virus 1 Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5282-9 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
PV1 Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); i; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Polio virus type I; Poliovirus; PV; PV1; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
52820-8 |
Observation |
Aper |
Pericard fld.spun |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Spun Pericardial fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
52820-8 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance spun Pcar |
|
|
|
N |
|
Appearance; Cardio; Cardiology; Heart Disease; Nominal; PCAR; Pericardial Fluid; Point in time; Random; SPEC; spun Pcar; Supernat; Supernate |
2.79 |
2.24 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
52821-6 |
Saint Louis encephalitis virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Saint Louis encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
positive, negative |
|
|
|
|
|
MICRO |
|
52821-6 |
|
IA |
|
|
Observation |
|
|
|
0 |
SLEV IgG Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SLE virus; SLEV; SR; St Louis; SUDS |
2.56 |
2.24 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
52822-4 |
Eastern equine encephalitis virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
positive, negative |
|
|
|
|
|
MICRO |
|
52822-4 |
|
IA |
|
|
Both |
|
|
|
0 |
EEEV IgG Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EEE virus; EEEV; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Togavirus |
2.56 |
2.24 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
52823-2 |
La Crosse virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
La Crosse virus IgG Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
positive, negative |
|
|
|
|
|
MICRO |
|
52823-2 |
|
IA |
|
|
Both |
|
|
|
0 |
LACV IgG Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.58 |
2.24 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
52824-0 |
La Crosse virus Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
La Crosse virus IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
positive, negative |
|
|
|
|
|
MICRO |
|
52824-0 |
|
IA |
|
|
Both |
|
|
|
0 |
LACV IgM Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.58 |
2.24 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
52825-7 |
La Crosse virus Ab.IgM |
PrThr |
CSF |
Pt |
Ord |
IA |
|
ACTIVE |
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
positive, negative |
|
|
|
|
|
MICRO |
|
52825-7 |
|
IA |
|
|
Both |
|
|
|
0 |
LACV IgM CSF Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS |
2.58 |
2.24 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
52826-5 |
Nursing management minimum data set panel |
- |
Facility |
Pt |
- |
NMMDS |
|
ACTIVE |
Nursing Management Minimum Data Set panel [NMMDS] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 2006 Diane Huber and Connie Delaney. Used with permission. |
|
|
|
|
PANEL.SURVEY.NMMDS |
|
52826-5 |
|
NMMDS |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
MDS; NMMDS Pnl; Nursing Management Minimum Data Set; Pan; PANEL.SURVEY.NMMDS; Panl; Pnl; Point in time; Random; Survey; SURVEY.NMMDS |
2.52 |
2.24 |
|
Panel |
|
|
Copyright �© 2006 Diane Huber and Connie Delaney. Used with permission. |
|
|
|
|
|
|
0 |
52827-3 |
Facility unique identifier panel |
- |
Facility |
Pt |
- |
NMMDS |
|
ACTIVE |
Facility unique identifier panel [NMMDS] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 2006 Diane Huber and Connie Delaney. Used with permission. |
|
|
|
|
PANEL.SURVEY.NMMDS |
|
52827-3 |
|
NMMDS |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Admin; Facility unique identifier Pnl; Nursing Management Minimum Data Set; Pan; PANEL.SURVEY.NMMDS; Panl; Pnl; Point in time; Random; Survey; SURVEY.NMMDS |
2.52 |
2.24 |
|
Panel |
|
|
Copyright �© 2006 Diane Huber and Connie Delaney. Used with permission. |
|
|
|
|
|
|
0 |
52828-1 |
Federal provider name |
ID |
Facility |
Pt |
Nom |
|
|
ACTIVE |
Federal provider name Facility |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.NMMDS |
|
52828-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Admin; Ident; Identifier; Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS |
2.27 |
2.24 |
|
|
|
|
|
|
|
|
|
|
|
0 |
52829-9 |
Place of service |
Type |
Facility |
Pt |
Nom |
|
|
ACTIVE |
Place of service |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.NMMDS |
|
52829-9 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Admin; Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS; Typ |
2.68 |
2.24 |
|
|
|
|
|
|
|
|
|
|
Added externally defined answer list for the CMS Place of service codes as a preferred list |
0 |